Kaisa Lehtomäki

7PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 03, 2026
Cost-effectiveness analysis of operative versus non-operative management of colorectal cancer metastases in the Finnish RAXO Study.

Joel Kontiainen, Kaisa Lehtomäki, Timo Muhonen

|Mar 13, 2024
Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study).

Sonja Aho, Emerik Osterlund, Ari Ristimäki

|Jul 14, 2023
Association between Computed Tomography-Determined Loss of Muscle Mass and Impaired Three-Month Survival in Frail Older Adults with Cancer.

Antti Tolonen, Hanna Kerminen, Kaisa Lehtomäki

|May 27, 2023
Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study).

Kaisa Lehtomäki, Leena-Maija Soveri, Emerik Osterlund

|Apr 13, 2023
Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer.

Kaisa Lehtomäki, Eetu Heervä, Pirkko-Liisa Kellokumpu-Lehtinen

|May 24, 2022
Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study.

Aki Uutela, Emerik Osterlund, Päivi Halonen

Pageof 2

Frequent Collaborators

7 joint publications

Pia Osterlund

5 joint publications

Aki Uutela

4 joint publications

Emerik Osterlund

4 joint publications

Bengt Glimelius